• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施和社区参与 DOTS 策略:在中国的研究系统评价。

Implementation and community involvement in DOTS strategy: a systematic review of studies in China.

机构信息

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan City, Hubei Province, China.

出版信息

Int J Tuberc Lung Dis. 2012 Nov;16(11):1433-40. doi: 10.5588/ijtld.12.0080.

DOI:10.5588/ijtld.12.0080
PMID:23044444
Abstract

OBJECTIVE

To summarise data on the implementation of the DOTS strategy in China in terms of actual observation and treatment adherence, and to review the effectiveness of quality improvement interventions for tuberculosis (TB) control in China.

DESIGN

We included survey studies that reported data on the implementation of DOTS in China and controlled studies that evaluated TB care in specified communities. We excluded studies outside mainland China, pharmacological intervention trials and reviews.

RESULTS

We included 12 survey studies that reported on the performance of TB control services in China. The pooled analysis showed that more than half of TB patients were treated by self-administration (52%) and that only 20% actually had their treatment observed by health workers. We include 85 intervention studies that evaluated the effect of quality improvement interventions. Treatment observers were family members in 37 studies, and health workers in 20 studies. The pooled odds ratio (OR) for cure was 2.48 (95%CI 1.97-3.11, I(2) = 70.9%, P < 0.001); the pooled OR for treatment completion was 2.87 (95%CI 2.23-3.69, I(2) = 66.3%, P < 0.001). Sensitivity analysis found that the estimated treatment effects in meta-analyses using reported and imputed data were much reduced, but still statistically significant.

CONCLUSION

The proportion of TB patients whose treatment was strictly observed was much lower than reported by official statistics in China. The treatment completion rate was not optimal, which may be an important reason for the reported increases in drug resistance. Community health personnel have become the main work force for TB control in China.

摘要

目的

总结中国实施直接督导下的短程化疗(DOTS)策略的数据,包括实际观察和治疗依从性,并回顾中国结核病(TB)控制质量改进干预的效果。

设计

我们纳入了报告中国 DOTS 实施情况的调查研究和评估特定社区 TB 护理的对照研究。我们排除了中国大陆以外的研究、药理学干预试验和综述。

结果

我们纳入了 12 项报告中国 TB 控制服务表现的调查研究。汇总分析显示,超过一半的 TB 患者接受自我管理治疗(52%),只有 20%的患者实际接受了卫生工作者的治疗观察。我们纳入了 85 项评估质量改进干预效果的干预研究。在 37 项研究中,治疗观察者是家庭成员,在 20 项研究中是卫生工作者。治愈率的合并优势比(OR)为 2.48(95%CI 1.97-3.11,I²=70.9%,P<0.001);治疗完成率的合并 OR 为 2.87(95%CI 2.23-3.69,I²=66.3%,P<0.001)。敏感性分析发现,使用报告和推断数据进行荟萃分析估计的治疗效果大大降低,但仍具有统计学意义。

结论

中国严格观察治疗的 TB 患者比例远低于官方统计报告的比例。治疗完成率不理想,这可能是报告中耐药性增加的一个重要原因。社区卫生人员已成为中国结核病控制的主要工作力量。

相似文献

1
Implementation and community involvement in DOTS strategy: a systematic review of studies in China.实施和社区参与 DOTS 策略:在中国的研究系统评价。
Int J Tuberc Lung Dis. 2012 Nov;16(11):1433-40. doi: 10.5588/ijtld.12.0080.
2
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Six-month therapy for abdominal tuberculosis.腹部结核的六个月治疗
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD012163. doi: 10.1002/14651858.CD012163.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013307. doi: 10.1002/14651858.CD013307.pub2.
10
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.非 ICU 住院患者预防谵妄的非药物干预措施。
Cochrane Database Syst Rev. 2021 Nov 26;11(11):CD013307. doi: 10.1002/14651858.CD013307.pub3.

引用本文的文献

1
Long-term trends and future projections of the burden of tuberculosis among children and adolescents in China.中国儿童和青少年结核病负担的长期趋势及未来预测。
PLoS One. 2025 Jul 17;20(7):e0328255. doi: 10.1371/journal.pone.0328255. eCollection 2025.
2
Analysis of epidemiological trends and risk factors in high-risk areas for pulmonary tuberculosis: an observational longitudinal study in Xinjiang, China.肺结核高风险地区的流行病学趋势及危险因素分析:一项在中国新疆开展的纵向观察性研究
BMJ Open. 2025 Feb 7;15(2):e087413. doi: 10.1136/bmjopen-2024-087413.
3
Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review.
数字技术在支持结核病治疗依从性方面的成本和成本效益:系统评价。
BMJ Glob Health. 2024 Oct 30;9(10):e015654. doi: 10.1136/bmjgh-2024-015654.
4
Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.中国湖南省耐多药结核病患者诊断和治疗延误的危险因素。
BMC Infect Dis. 2024 Feb 2;24(1):159. doi: 10.1186/s12879-024-09036-2.
5
Digital tool assessment for the community management of patients with pulmonary tuberculosis in Yiwu city, China: evidence from real world data in 2020.中国义乌市肺结核患者社区管理的数字化工具评估:2020 年真实世界数据证据。
Front Public Health. 2024 Jan 8;11:1320904. doi: 10.3389/fpubh.2023.1320904. eCollection 2023.
6
Tuberculosis in older adults: challenges and best practices in the Western Pacific Region.西太平洋地区老年人结核病:挑战与最佳实践
Lancet Reg Health West Pac. 2023 Apr 20;36:100770. doi: 10.1016/j.lanwpc.2023.100770. eCollection 2023 Jul.
7
Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study.中国上海移动健康提醒对结核病治疗结局的影响:一项前瞻性队列研究。
Front Public Health. 2023 Apr 27;11:923319. doi: 10.3389/fpubh.2023.923319. eCollection 2023.
8
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial.数字依从性技术改善中国结核病治疗结局:一项集群随机优势试验。
Lancet Glob Health. 2023 May;11(5):e693-e703. doi: 10.1016/S2214-109X(23)00068-2.
9
Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020-2021: Impact on medication adherence.2020-2021 年中国武汉市结核病治疗监测数字化:对药物依从性的影响。
Front Public Health. 2023 Mar 1;11:1033532. doi: 10.3389/fpubh.2023.1033532. eCollection 2023.
10
Tuberculosis in older adults: case studies from four countries with rapidly ageing populations in the western pacific region.老年人结核病:来自西太平洋地区人口迅速老龄化的四个国家的案例研究。
BMC Public Health. 2023 Feb 21;23(1):370. doi: 10.1186/s12889-023-15197-7.